United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News Axsome Therapeutics wins big in Auvelity patent battle, stock jumps 14% Axsome Therapeutics Inc. experienced a sharp rise in its share price, climbing 14% in premarket trading following the… byPallavi MadhirajuFebruary 10, 2025